EN
HI

Orchid Pharma Share price

ORCHPHARMA

704

10.60 (-1.48%)
NSE
BSE
Last updated on 11 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

731.55

Today's Low

702.50

52 Week Low

603.80

52 Week High

1997.40

The current prices are delayed, login to your account for live prices

Orchid Pharma Share Key Metrics

Volume
62929.00
Market Cap
3624.39 CR
LTQ@LTP
2@704.00
ATP
717.11
Var Margin
23.37 %
Circuit Range
643.15-786.05
Delivery %
67.95 %
Value
4.51 CR
ASM/GSM
No
Market Lot
1

Orchid Pharma Futures & Options

Data Not Found

Orchid Pharma Corporate Actions

DateAgenda
2025-08-12Quarterly Results
2025-05-26Audited Results

Orchid Pharma News

Orchid Pharma Standalone June 2024 Net Sales at Rs 244.41 crore, up 33.61% Y-o-Y

Aug 17 2024 10:36:56
Read More

About Orchid Pharma

NSE : 926  
BSE : 524372  
ISIN : INE191A01027  

Orchid Chemicals & Pharmaceuticals Limited (ORCHID) as incorporated as a Public Limited Company on July 01 1992 under the Companies Act 1956. The Company obtained Certificate of Commencement of Business on October 15 1992. ORCHID has its registered office at Madras ORCHID hasset up a 100% Export Oriented Unit for the manufacture of 7 ADCA (intermediate) Cephalexin Cefradine and Cefadroxyl bulk drugs at a cost of Rs.1195 lakhs in technical and financial collaboration with Sintofarm SPA Italy. This unit is located at SIDCO Pharmaceutical Zone Alathur Tamilnadu. The Project was completed two months ahead ofschedule and after successful trial runs in Jan-94 commercial operations commenced from Feb. 94. In Feb 94 ORCHID undertook a Scheme at a cost of Rs.160 lakhs for better recovery of solvents backward integration and process optimization. During its first two months of operations the Company''s unit achieved a capacity utilization of 80% and produced 12.1 tonnes of Cephalexin out of which 11.7 tonnes (97%) was exported.The products are exported to Germany Italy Switzerland Holland Spain Cyprus Hongkong Singapore etc. and have been well received in the International Markets resulting in repeat orders.

Read More

Orchid Pharma Management

NamePosition
Mr. Ram Gopal Agarwal Chairman & Non-Exe.Director
Mr. Manish Dhanuka Managing Director
View More

Orchid Pharma FAQs

The Buying Price of Orchid Pharma share is 704 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Orchid Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Orchid Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Orchid Pharma shares is 42.43. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Orchid Pharma shares is 2.82. Useful to assess the stock's value relative to its book value.

To assess Orchid Pharma’s valuation compare Sector P/E, P/B which are 39.61 & 3.74 with sector averages, along with growth rates and financial metrics.

The Market Cap of Orchid Pharma is 3624.39 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Orchid Pharma share price is 1997.40 & 603.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Orchid Pharma belongs to the Healthcare sector.